SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-07-047342
Filing Date
2007-08-30
Accepted
2007-08-30 17:36:15
Documents
1
Period of Report
2007-05-29

Document Format Files

Seq Description Document Type Size
1 v086707_ex.html 3  
1 v086707_ex.xml 3 2677
  Complete submission text file 0001144204-07-047342.txt   4502
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 POST STREET SUITE 900 SAN FRANCISCO CA 94108
Business Address 415-677-9677
Masterson Nola E (Reporting) CIK: 0001305231 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 071092453